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ABSTRACT
Besides its antiarrhythmic effect on atrial fibrillation, 
bepridil protects tissue, yet its effect on apoptosis has 
never been fully tested. We examine the effect of bepridil 
on apoptosis of HL-1 cells expressing E334K myosin-
binding protein C (MyBPC), a model cell of apoptosis. 
Bepridil was compared with amiodarone, and its effects 
on the expression of pro- and anti-apoptotic protein and 
apoptosis of HL-1 cells expressing mutant E334K MyB-
PC-green fluorescent protein (GFP) was analyzed using 
Western blot and a flow cytometer. Bepridil decreased 
the protein levels of both Bax and cytochrome c of cells 
expressing E334K MyBPC-GFP with no changes in p53 
and Bcl-2, while amiodarone decreased cytochrome c 
but did not influence Bax except in its highest concentra-
tion. It also decreased the number of Annexin-V positive 
cells of HL-1 cells expressing E334K MyBPC-GFP, and 
decreased apoptosis of HL-1 cells expressing E334K 
MyBPC-GFP. 
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Bepridil is classified as a Ca2+ channel blocker accord-
ing to Vaughn-Williams’ classification.1 This agent also 
has multi-ion channel blocking effects similar to those 
of amiodarone and is thought to be effective for atrial 
fibrillation.2 Along with its electrophysiological actions 
on atrial myocytes, bepridil showed beneficial effects in 
tissue protection from ischemia.3 However, it remains 
unknown whether bepridil protects the apoptosis of 
atrial myocytes. Recently, we proposed cultured mouse 
atrial myocytes (HL-1 cells) expressing a Glu344Lys 
(E334K) missense mutation of myosin-binding protein 
C (MyBPC) as the model to induce apoptosis.4 These 
cells exhibit apoptosis with increased pro-apoptotic pro-
teins and decreased anti-apoptotic protein. In the present 
study, we studied the effect of bepridil on apoptosis in 
HL-1 cells expressing mutant MyBPC in comparison 
with amiodarone.  
 
MATERIALS AND METHODS
Cells culture and heterologous expression 
HL-1 cardiac myocytes were provided by Dr. Claycomb 
(Louisiana State University) and cultured according to 
instructions.5 cDNA encoding E334K cardiac MyBPC 
(cMyBPC) with a 6-myc tag at the N-terminus4 was 
ligated to pCS2+ at BamHI and XhoI sites to generate 
plasmid expression vectors pCS-6myc-MYBPC3. To vi-
sualize the transfected cells, enhanced green fluorescent 
protein (EGFP) cDNA was added to the carboxy termi-
nus of E334K MyBPC cDNA. Transfection into HL-1 
cells was performed using lipofectamin 2000 (Invitrogen, 
Carlsbad, CA) following the manufacturer’s instructions. 
 
Western blotting
E334K MYBPC3 was transfected into HL-1 cells in the 
absence or presence of either bepridil or amiodarone. 
Protein extracts of cells were prepared 48 h post-trans-
fection, as described elsewhere.5 Proteins were separated 
by SDS-PAGE and electrotransferred to polyvinylidene 
difluoride membrane. Membranes were probed with an-
tibodies to actin (Calbiochem, La Jolla, CA), p53 (Santa 
Cruz Biotechnology, Santa Cruz, CA), Bax (Santa Cruz), 
cytochrome c (BD Biosciences, Franklin Lakes, NJ) or 
Bcl-2 (Santa Cruz). They were developed using an ECL 
system (Amersham Bioscience, Piscataway, NJ). The 
intensities of the bands were quantified using National 
Institute of Health image Software. 
 
Annexin V staining and flow cytometry 
Annexin V staining and flow cytometer of E334K 
MYBPC3-GFP transfected cells were performed in the 
absence and presence of either bepridil or amiodarone as 
reported elsewhere.4
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Fig. 1. Effects of bepridil and amiodarone on apoptosis in HL-1 cardiac atrial myocytes expressing E334K cMyBPC.
  A:  Effect of bepridil and amiodarone on the level of proteins regulating apoptosis in HL-1 cells expressing E334K cMyBPC in a dose-
dependent manner. Representative Western blot of pro-apoptotic proteins cytochrome c and Bax in HL-1 cells transfected with E334K 
cMyBPC in the presence or absence of drugs as indicated. Beta-actin used as a control for protein loading. Summary of quantitative 
densitometric scan of drugs on the level of Bax and cytochrome c; n = 8, *P < 0.05; **P < 0.01. cMyBPC, cardiac myosin-binding 
protein C. 
  B: Effect of bepridil on the apoptotic cells expressing E334K cMyBPC-GFP.
(a) The representative immunofluorescence image of annexin V-positive cells in cells expressing E334K cMyBPC-GFP before and after 
treatment with bepridil.
(b) The percentage of annexin V-positive cells (n = 4) in those cells. Data are shown as mean (SEM), calculated by unpaired, two-tailed 
Student’s t-test. *P < 0.05.
GFP, green fluorescent protein.
Used drugs
Amiodarone and bepridil were used in this study. Be-
pridil was kindly provided by Daiichi Sankyo (Tokyo, 
Japan) and amiodarone was purchased from Sigma-
Aldrich Japan (Tokyo). 
 
Statistical analysis 
Origin for Windows software version 7.0 (OriginLab 
Corporation, Northampton, MA) was used for statisti-
cal analysis. Differences between the 2 groups were as-
sessed using the two-sample t-test. One-way analysis of 
variance with the Bonferroni test for post-hoc analysis 
was used for multiple comparisons. All experimental 
data were expressed as the mean (SEM). Differences 
with P values < 0.05 were considered significant. 
 
RESULTS AND DISCUSSION
Figure 1A shows the effects of bepridil or amiodarone 
on the level of proteins that regulate apoptosis in HL-1 
cells expressing E334K MyBPC. Bepridil decreased the 
levels of Bax and cytochrome c, but not those of either 
p53 or Bcl-2 in cells expressing E334K MyBPC (data not 
shown), which was also confirmed by quantitative analy-
sis obtained from 6 different experiments. Amiodarone 
also decreased the level of cytochrome c, while it de-
creased the level of Bax at the highest concentration. 
Next, we examined the effect of bepridil on apoptosis of 
HL-1 cells expressing E334K MyBPC-GFP as shown in 
Fig. 1B. Bepridil reduced the number of annexin V-pos-
itive cells, which was confirmed by quantitative analysis 
(n = 4). 
 It has been reported that bepridil blocked the several 
cardiac ion channels and was protective against atrial 
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fibrillation (Af). In addition to its acute action on ion 
channels, bepridil reversed atrial electrical remodeling 
and L-type Ca2+ channel down regulation in a canine 
model of persistent Af,6 suggesting that bepridil can ex-
ert beneficial effects on electrophysiological properties 
of atrial myocytes via modulating expression of ionic 
channels. Some research has found that bepridil protects 
cardiac myocytes from ischemia; impaired mitochon-
drial function, increasing reactive oxygen species, and 
apoptosis are involved in age-related atrial remodeling 
and Af susceptibility.7, 8 Other research has shown that it 
reduces reactive oxygen species, and thus, is expected to 
reduce apoptosis. In the present study, bepridil reduced 
the level of pro-apoptotic proteins (cytochrome c and 
Bax) of cells expressing MyBPC-GFP, and this effect 
was prominent in comparison with that of amiodarone. 
The reduction of the level of cytochrome c suggested 
protective effect of bepridil that was mediated through 
the mitochondrial pathway. Although bepridil inhibited 
Na+/Ca2+ exchanger and suppressed apoptosis of neu-
rons,9 this is the first report demonstrating the effect 
of bepridil on apoptosis in a cellular model expressing 
E334K MyBPC. 
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